Authors: Sharon Salt, Editor
In this week’s industry news round-up, we’ve chosen the latest updates from a wide range of disorders extending from depression to multiple sclerosis. Find out more about our selection of the highlights below.
Our pick of the headlines include:
Novartis to seek FDA approval after additional Phase III data for siponimod in SPMS announcedRestricted Content / Members Only